Publication | Open Access

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group

Surgical OncologyPancreatic CancerPhase Ii TrialGastrointestinal OncologyMedicineSurgeryResectable Pancreatic CancerCancer TreatmentOncology